|
1
|
Weigelt B, Peterse JL and van’t Veer LJ:
Breast cancer metastasis: markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scully OJ, Bay BH, Yip G and Yu Y: Breast
cancer metastasis. Cancer Genomics Proteomics. 9:311–320.
2012.PubMed/NCBI
|
|
3
|
Stetler-Stevenson WG, Aznavoorian S and
Liotta LA: Tumor cell interactions with the extracellular matrix
during invasion and metastasis. Annu Rev Cell Biol. 9:541–573.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vihinen P and Kahari VM: Matrix
metalloproteinases in cancer: prognostic markers and therapeutic
targets. Int J Cancer. 99:157–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kondraganti S, Mohanam S, Chintala SK, et
al: Selective suppression of matrix metalloproteinase-9 in human
glioblastoma cells by antisense gene transfer impairs glioblastoma
cell invasion. Cancer Res. 60:6851–6855. 2000.
|
|
6
|
Lakka SS, Gondi CS, Yanamandra N, et al:
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma
cell line via RNA interference reduces tumor cell invasion, tumor
growth and angiogenesis. Oncogene. 23:4681–4689. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Itoh T, Tanioka M, Matsuda H, et al:
Experimental metastasis is suppressed in MMP-9-deficient mice. Clin
Exp Metastasis. 17:177–181. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji MK, Shi Y, Xu JW, et al: Recombinant
snake venom metalloproteinase inhibitor BJ46A inhibits invasion and
metastasis of B16F10 and MHCC97H cells through reductions of matrix
metalloproteinases 2 and 9 activities. Anticancer Drugs.
24:461–472. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shishu, Singla AK and Kaur IP: Inhibitory
effect of dibenzoylmethane on mutagenicity of food-derived
heterocyclic amine mutagens. Phytomedicine. 10:575–582. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin CC, Lu YP, Lou YR, et al: Inhibition
by dietary dibenzoylmethane of mammary gland proliferation,
formation of DMBA-DNA adducts in mammary glands, and mammary
tumorigenesis in Sencar mice. Cancer Lett. 168:125–132. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singletary K and MacDonald C: Inhibition
of benzo[a]pyrene- and 1,6-dinitropyrene-DNA adduct formation in
human mammary epithelial cells bydibenzoylmethane and sulforaphane.
Cancer Lett. 155:47–54. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheung KL, Khor TO, Huang MT and Kong AN:
Differential in vivo mechanism of chemoprevention of tumor
formation in azoxymethane/dextran sodium sulfate mice by PEITC and
DBM. Carcinogenesis. 31:880–885. 2010. View Article : Google Scholar :
|
|
13
|
Singletary K, MacDonald C, Iovinelli M,
Fisher C and Wallig M: Effect of the beta-diketones
diferuloylmethane (curcumin) and dibenzoylmethane on rat mammary
DNA adducts and tumors induced by 7,12-dimethylbenz[a]anthracene.
Carcinogenesis. 19:1039–1043. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jackson KM, DeLeon M, Verret CR and Harris
WB: Dibenzoylmethane induces cell cycle deregulation in human
prostate cancer cells. Cancer Lett. 178:161–165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan MH, Sin YH, Lai CS, et al: Induction
of apoptosis by 1-(2-hydr
oxy-5-methylphenyl)-3-phenyl-1,3-propanedione through reactive
oxygen species production, GADD153 expression, and caspases
activation in human epidermoid carcinoma cells. J Agric Food Chem.
53:9039–9049. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weng CJ, Yang YT, Ho CT and Yen GC:
Mechanisms of apoptotic effects induced by resveratrol,
dibenzoylmethane, and their analogues on human lung carcinoma
cells. J Agric Food Chem. 57:5235–5243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu CL, Liao YF, Hung YC, Lu KH, Hung HC
and Liu GY: Ornithine decarboxylase prevents
dibenzoylmethane-induced apoptosis through repressing reactive
oxygen species generation. J Biochem Mol Toxicol. 25:312–319. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pan MH, Huang MC, Wang YJ, Lin JK and Lin
CH: Induction of apoptosis by hydroxydibenzoylmethane through
coordinative modulation of cyclin D3, Bcl-X(L), and Bax, release of
cytochrome c, and sequential activation of caspases in human
colorectal carcinoma cells. J Agric Food Chem. 51:3977–3984. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liao YF, Rao YK and Tzeng YM: Aqueous
extract of Anisomeles indica and its purified compound exerts
anti-metastatic activity through inhibition of
NF-kappaB/AP-1-dependent MMP-9 activation in human breast cancer
MCF-7 cells. Food Chem Toxicol. 50:2930–2936. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duffy MJ, Maguire TM, Hill A, McDermott E
and O’Higgins N: Metalloproteinases: Role in breast carcinogenesis,
invasion and metastasis. Breast Cancer Res. 2:252–257. 2000.
View Article : Google Scholar
|
|
21
|
Park SK, Hwang YS, Park KK, Park HJ, Seo
JY and Chung WY: Kalopanaxsaponin A inhibits PMA-induced invasion
by reducing matrix metalloproteinase-9 via PI3K/Akt- and
PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Carcinogenesis. 30:1225–1233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu HS, Lin TH and Tang CH: Bradykinin
enhances cell migration in human prostate cancer cells through B2
receptor/PKCdelta/c-Src dependent signaling pathway. Prostate.
73:89–100. 2013. View Article : Google Scholar
|
|
23
|
Pockaj BA, Wasif N, Dueck AC, et al:
Metastasectomy and surgical resection of the primary tumor in
patients with stage IV breast cancer: time for a second look? Ann
Surg Oncol. 17:2419–2426. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Johnson KA and Brown PH: Drug development
for cancer chemoprevention: focus on molecular targets. Semin
Oncol. 37:345–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weng CJ and Yen GC: Chemopreventive
effects of dietary phytochemicals against cancer invasion and
metastasis: phenolic acids, monophenol, polyphenol, and their
derivatives. Cancer Treat Rev. 38:76–87. 2012. View Article : Google Scholar
|
|
26
|
Kandaswami C, Lee LT, Lee PP, et al: The
antitumor activities of flavonoids. In Vivo. 19:895–909.
2005.PubMed/NCBI
|
|
27
|
Nogueira MA, Magalhaes EG, Magalhaes AF,
et al: A novel sunscreen agent having antimelanoma activity.
Farmaco. 58:1163–1169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dinkova-Kostova AT and Talalay P: Relation
of structure of curcumin analogs to their potencies as inducers of
Phase 2 detoxification enzymes. Carcinogenesis. 20:911–914. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brummer O, Athar S, Riethdorf L, Loning T
and Herbst H: Matrix-metalloproteinases 1, 2, and 3 and their
tissue inhibitors 1 and 2 in benign and malignant breast lesions:
an in situ hybridization study. Virchows Arch. 435:566–573. 1999.
View Article : Google Scholar
|
|
30
|
Mishra A, Paul S and Swarnakar S:
Downregulation of matrix metalloproteinase-9 by melatonin during
prevention of alcohol-induced liver injury in mice. Biochimie.
93:854–866. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang MT, Lou YR, Xie JG, et al: Effect of
dietary curcumin and dibenzoylmethane on formation of
7,12-dimethylbenz[a] anthracene-induced mammary tumors and
lymphomas/leukemias in Sencar mice. Carcinogenesis. 19:1697–1700.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin CW, Hou WC, Shen SC, et al: Quercetin
inhibition of tumor invasion via suppressing PKC
delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in
breast carcinoma cells. Carcinogenesis. 29:1807–1815. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sim GS, Lee BC, Cho HS, et al: Structure
activity relationship of antioxidative property of flavonoids and
inhibitory effect on matrix metalloproteinase activity in
UVA-irradiated human dermal fibroblast. Arch Pharm Res. 30:290–298.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu WS and Heckman CA: The sevenfold way
of PKC regulation. Cell Signal. 10:529–542. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matsuoka H, Tsubaki M, Yamazoe Y, et al:
Tamoxifen inhibits tumor cell invasion and metastasis in mouse
melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt
pathways. Exp Cell Res. 315:2022–2032. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hussaini IM, Trotter C, Zhao Y, et al:
Matrix metalloproteinase-9 is differentially expressed in
nonfunctioning invasive and noninvasive pituitary adenomas and
increases invasion in human pituitary adenoma cell line. Am J
Pathol. 170:356–365. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Woo JH, Lim JH, Kim YH, et al: Resveratrol
inhibits phorbol myristate acetate-induced matrix
metalloproteinase-9 expression by inhibiting JNK and PKC delta
signal transduction. Oncogene. 23:1845–1853. 2004. View Article : Google Scholar
|
|
38
|
Vuong H, Patterson T, Shapiro P, et al:
Phorbol ester-induced expression of airway squamous cell
differentiation marker, SPRR1B, is regulated by protein kinase
Cdelta/Ras/MEKK1/MKK1-dependent/AP-1 signal transduction pathway. J
Biol Chem. 275:32250–32259. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chang JT, Lu YC, Chen YJ, et al: hTERT
phosphorylation by PKC is essential for telomerase holoprotein
integrity and enzyme activity in head neck cancer cells. Br J
Cancer. 94:870–878. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin CC, Tsai YL, Huang MT, et al:
Inhibition of estradiol-induced mammary proliferation by
dibenzoylmethane through the E2-ER-ERE-dependent pathway.
Carcinogenesis. 27:131–136. 2006. View Article : Google Scholar
|
|
41
|
Lee KW, Kim MS, Kang NJ, et al: H-Ras
selectively up-regulates MMP-9 and COX-2 through activation of
ERK1/2 and NF-kappaB: an implication for invasive phenotype in rat
liver epithelial cells. Int J Cancer. 119:1767–1775. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
George J, Banik NL and Ray SK: Knockdown
of hTERT and concurrent treatment with interferon-gamma inhibited
proliferation and invasion of human glioblastoma cell lines. Int J
Biochem Cell Biol. 42:1164–1173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Park EJ, Lim JH, Nam SI, Park JW and Kwon
TK: Rottlerin induces heme oxygenase-1 (HO-1) up-regulation through
reactive oxygen species (ROS) dependent and PKC delta-independent
pathway in human colon cancer HT29 cells. Biochimie. 92:110–115.
2010. View Article : Google Scholar
|
|
44
|
Pan YC, Li CF, Ko CY, et al: CEBPD
reverses RB/E2F1-mediated gene repression and participates in
HMDB-induced apoptosis of cancer cells. Clin Cancer Res.
16:5770–5780. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee KH and Kim JR: Kiss-1 suppresses MMP-9
expression by activating p38 MAP kinase in human stomach cancer.
Oncol Res. 18:107–116. 2009. View Article : Google Scholar
|
|
46
|
Adamo B, Deal AM, Burrows E, et al:
Phosphatidylinositol 3-kinase pathway activation in breast cancer
brain metastases. Breast Cancer Res. 13:R1252011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cuevas BD, Lu Y, Mao M, et al: Tyrosine
phosphorylation of p85 relieves its inhibitory activity on
phosphatidylinositol 3-kinase. J Biol Chem. 276:27455–27461. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu C, Su T, Li F, et al: PI3K/Akt
signaling transduction pathway is involved in rat vascular smooth
muscle cell proliferation induced by apelin-13. Acta Biochim
Biophys Sin (Shanghai). 42:396–402. 2010. View Article : Google Scholar
|
